Reports - Smart Pill Technology Market
HealthcareSmart Pill Technology Market
Smart Pill Technology Market Valuation and Future Projections to 2035 by Technology (Capsule Endoscopy, Patient Monitoring, Drug Delivery), by Disease (Crohn’s Disease, Celiac Disease, Inherited Polyposis Syndromes, Small Bowel Tumors), by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Smart Pill Technology Market - Segment Analysis
1. Overview
2. Global Smart Pill Technology Market, 2021 - 2035 (USD Million)
3. Global Smart Pill Technology Market - by Technology
3.1. By Capsule Endoscopy
3.2. By Patient Monitoring
3.3. By Drug Delivery
4. Global Smart Pill Technology Market - by Disease
4.1. By Crohn’s Disease
4.2. By Celiac Disease
4.3. By Inherited Polyposis Syndromes
4.4. By Small Bowel Tumors
4.5. By Occult GI Bleeding
4.6. By Others
5. Global Smart Pill Technology Market - by region
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Latin America
5.5. Middle East & Africa
6. Market comparative analysis
Chapter 4 North America Smart Pill Technology Market - Segment Analysis
1. Overview
2. North America Smart Pill Technology Market, 2021 - 2035 (USD Million)
3. North America Smart Pill Technology Market - by Technology
3.1. By Capsule Endoscopy
3.2. By Patient Monitoring
3.3. By Drug Delivery
4. North America Smart Pill Technology Market - by Disease
4.1. By Crohn’s Disease
4.2. By Celiac Disease
4.3. By Inherited Polyposis Syndromes
4.4. By Small Bowel Tumors
4.5. By Occult GI Bleeding
4.6. By Others
Chapter 5 Europe Smart Pill Technology Market - Segment Analysis
1. Overview
2. Europe Smart Pill Technology Market, 2021 - 2035 (USD Million)
3. Europe Smart Pill Technology Market - by Technology
3.1. By Capsule Endoscopy
3.2. By Patient Monitoring
3.3. By Drug Delivery
4. Europe Smart Pill Technology Market - by Disease
4.1. By Crohn’s Disease
4.2. By Celiac Disease
4.3. By Inherited Polyposis Syndromes
4.4. By Small Bowel Tumors
4.5. By Occult GI Bleeding
4.6. By Others
Chapter 6 Asia Pacific Smart Pill Technology Market - Segment Analysis
1. Overview
2. Asia Pacific Smart Pill Technology Market, 2021 - 2035 (USD Million)
3. Asia Pacific Smart Pill Technology Market - by Technology
3.1. By Capsule Endoscopy
3.2. By Patient Monitoring
3.3. By Drug Delivery
4. Asia Pacific Smart Pill Technology Market - by Disease
4.1. By Crohn’s Disease
4.2. By Celiac Disease
4.3. By Inherited Polyposis Syndromes
4.4. By Small Bowel Tumors
4.5. By Occult GI Bleeding
4.6. By Others
Chapter 7 Latin America Smart Pill Technology Market - Segment Analysis
1. Overview
2. Latin America Smart Pill Technology Market, 2021 - 2035 (USD Million)
3. Latin America Smart Pill Technology Market - by Technology
3.1. By Capsule Endoscopy
3.2. By Patient Monitoring
3.3. By Drug Delivery
4. Latin America Smart Pill Technology Market - by Disease
4.1. By Crohn’s Disease
4.2. By Celiac Disease
4.3. By Inherited Polyposis Syndromes
4.4. By Small Bowel Tumors
4.5. By Occult GI Bleeding
4.6. By Others
Chapter 8 Middle East & Africa Smart Pill Technology Market - Segment Analysis
1. Overview
2. Middle East & Africa Smart Pill Technology Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Smart Pill Technology Market - by Technology
3.1. By Capsule Endoscopy
3.2. By Patient Monitoring
3.3. By Drug Delivery
4. Middle East & Africa Smart Pill Technology Market - by Disease
4.1. By Crohn’s Disease
4.2. By Celiac Disease
4.3. By Inherited Polyposis Syndromes
4.4. By Small Bowel Tumors
4.5. By Occult GI Bleeding
4.6. By Others
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. CapsoVision Inc. (U.S.)
2. Given Imaging Inc. (Israel)
3. Medimetrics S.A. de C.V. (Mexico)
4. Olympus Corporation (Japan)
5. and Bio-Images Research Limited (U.K.)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By